Paul Bastard
Université Claude Bernard Lyon 1(FR)Hôpital Necker-Enfants Malades(FR)Inserm(FR)Université Sorbonne Nouvelle(FR)Université Paris Cité(FR)Sorbonne Université(FR)Institut Necker Enfants Malades(FR)Hospital for Sick Children Pediatric Center(US)Centre de Référence Déficits Immunitaires Héréditaires(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Hospices Civils de Lyon(FR)Pediatrics and Genetics(US)Human Genetic of Infectious Diseases(FR)Institut des Maladies Génétiques Imagine(FR)Rockefeller University(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immunodeficiency and Autoimmune Disorders, Long-Term Effects of COVID-19, interferon and immune responses
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → Inborn errors of type I IFN immunity in patients with life-threatening COVID-19(2020)2,377 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → Human genetic and immunological determinants of critical COVID-19 pneumonia(2022)384 cited
- → Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1(2021)300 cited
- → Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19(2021)233 cited